REPORT ID 1503

United States Orlistat Market Report 2017

Publish Date
06-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the United States Orlistat market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Orlistat in these regions, from 2012 to 2022 (forecast).

United States Orlistat market competition by top manufacturers/players, with Orlistat sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    GSK group
    Teva
    Sandoz(Novartis)
    STADA-VN J.V.Co., Ltd
    Hexal AG
    National Company for Pharmaceutical Industry
    Lunan Pharmaceutical Group Corporation
    ZEIN pharmaceutical
    HISUN
    Taj Pharmaceuticals Ltd
    Kabir Life Sciences & Research
    DM Pharma
    China Zhongshan Pharm

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    120mg
    60mg
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Weight-reducing Aid
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Orlistat Market Report 2017
1 Orlistat Overview
    1.1 Product Overview and Scope of Orlistat
    1.2 Classification of Orlistat by Product Category
        1.2.1 United States Orlistat Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Orlistat Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 120mg
        1.2.4 60mg
    1.3 United States Orlistat Market by Application/End Users
        1.3.1 United States Orlistat Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Weight-reducing Aid
        1.3.3 Other
    1.4 United States Orlistat Market by Region
        1.4.1 United States Orlistat Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Orlistat Status and Prospect (2012-2022)
        1.4.3 Southwest Orlistat Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Orlistat Status and Prospect (2012-2022)
        1.4.5 New England Orlistat Status and Prospect (2012-2022)
        1.4.6 The South Orlistat Status and Prospect (2012-2022)
        1.4.7 The Midwest Orlistat Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Orlistat (2012-2022)
        1.5.1 United States Orlistat Sales and Growth Rate (2012-2022)
        1.5.2 United States Orlistat Revenue and Growth Rate (2012-2022)

2 United States Orlistat Market Competition by Players/Suppliers
    2.1 United States Orlistat Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Orlistat Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Orlistat Average Price by Players/Suppliers (2012-2017)
    2.4 United States Orlistat Market Competitive Situation and Trends
        2.4.1 United States Orlistat Market Concentration Rate
        2.4.2 United States Orlistat Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Orlistat Manufacturing Base Distribution, Sales Area, Product Type

3 United States Orlistat Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Orlistat Sales and Market Share by Region (2012-2017)
    3.2 United States Orlistat Revenue and Market Share by Region (2012-2017)
    3.3 United States Orlistat Price by Region (2012-2017)

4 United States Orlistat Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Orlistat Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Orlistat Revenue and Market Share by Type (2012-2017)
    4.3 United States Orlistat Price by Type (2012-2017)
    4.4 United States Orlistat Sales Growth Rate by Type (2012-2017)

5 United States Orlistat Sales (Volume) by Application (2012-2017)
    5.1 United States Orlistat Sales and Market Share by Application (2012-2017)
    5.2 United States Orlistat Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Orlistat Players/Suppliers Profiles and Sales Data
    6.1 Roche
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Orlistat Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Roche Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GSK group
        6.2.2 Orlistat Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GSK group Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Teva
        6.3.2 Orlistat Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Teva Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Sandoz(Novartis)
        6.4.2 Orlistat Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Sandoz(Novartis) Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 STADA-VN J.V.Co., Ltd
        6.5.2 Orlistat Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 STADA-VN J.V.Co., Ltd Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Hexal AG
        6.6.2 Orlistat Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Hexal AG Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 National Company for Pharmaceutical Industry
        6.7.2 Orlistat Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 National Company for Pharmaceutical Industry Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Lunan Pharmaceutical Group Corporation
        6.8.2 Orlistat Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Lunan Pharmaceutical Group Corporation Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 ZEIN pharmaceutical
        6.9.2 Orlistat Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 ZEIN pharmaceutical Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 HISUN
        6.10.2 Orlistat Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 HISUN Orlistat Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Taj Pharmaceuticals Ltd
    6.12 Kabir Life Sciences & Research
    6.13 DM Pharma
    6.14 China Zhongshan Pharm

7 Orlistat Manufacturing Cost Analysis
    7.1 Orlistat Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Orlistat

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Orlistat Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Orlistat Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Orlistat Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Orlistat Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Orlistat Sales Volume Forecast by Type (2017-2022)
    11.3 United States Orlistat Sales Volume Forecast by Application (2017-2022)
    11.4 United States Orlistat Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer